Response to the novel corona virus (COVID-19) pandemic across Africa: successes, challenges, and implications for the future OO Ogunleye, D Basu, D Mueller, J Sneddon, RA Seaton, ... Frontiers in pharmacology 11, 1205, 2020 | 215 | 2020 |
Ongoing initiatives to improve the quality and efficiency of medicine use within the public healthcare system in South Africa; a preliminary study JC Meyer, N Schellack, J Stokes, R Lancaster, H Zeeman, D Defty, ... Frontiers in pharmacology 8, 751, 2017 | 180 | 2017 |
Strategies to improve antimicrobial utilization with a special focus on developing countries B Godman, A Egwuenu, M Haque, OO Malande, N Schellack, S Kumar, ... Life 11 (6), 528, 2021 | 176 | 2021 |
Barriers for access to new medicines: searching for the balance between rising costs and limited budgets B Godman, A Bucsics, P Vella Bonanno, W Oortwijn, CC Rothe, A Ferrario, ... Frontiers in Public Health 6, 328, 2018 | 164 | 2018 |
Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries … B Godman, M Haque, J McKimm, M Abu Bakar, J Sneddon, J Wale, ... Current medical research and opinion 36 (2), 301-327, 2020 | 160 | 2020 |
Review of ongoing activities and challenges to improve the care of patients with type 2 diabetes across Africa and the implications for the future B Godman, D Basu, Y Pillay, JC Mwita, GM Rwegerera, ... Frontiers in pharmacology 11, 108, 2020 | 125 | 2020 |
Medicine shortages and challenges with the procurement process among public sector hospitals in South Africa; findings and implications C Modisakeng, M Matlala, B Godman, JC Meyer BMC health services research 20, 1-10, 2020 | 116 | 2020 |
Fixed dose drug combinations–are they pharmacoeconomically sound? Findings and implications especially for lower-and middle-income countries B Godman, H McCabe, T D Leong, D Mueller, AP Martin, I Hoxha, ... Expert review of pharmacoeconomics & outcomes research 20 (1), 1-26, 2020 | 88 | 2020 |
Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications B Godman, A Hill, S Simoens, G Selke, I Selke Krulichová, ... Expert review of pharmacoeconomics & outcomes research 21 (4), 527-540, 2021 | 72 | 2021 |
A situational analysis of current antimicrobial governance, regulation, and utilization in South Africa N Schellack, D Benjamin, A Brink, A Duse, K Faure, D Goff, M Mendelson, ... International journal of infectious diseases 64, 100-106, 2017 | 71 | 2017 |
Retracted Article: Antidiabetic medication adherence and associated factors among patients in Botswana; implications for the future GM Rwegerera, T Moshomo, M Gaenamong, TA Oyewo, S Gollakota, ... Alexandria journal of medicine 54 (2), 103-109, 2018 | 64 | 2018 |
Tackling antimicrobial resistance across sub-Saharan Africa: Current challenges and implications for the future B Godman, A Egwuenu, E Wesangula, N Schellack, AC Kalungia, ... Expert Opinion on Drug Safety 21 (8), 1089-1111, 2022 | 63 | 2022 |
Identifying medication errors in the neonatal intensive care unit and paediatric wards using a medication error checklist at a tertiary academic hospital in Gauteng, South Africa A Truter, N Schellack, JC Meyer South African Journal of Child Health 11 (1), 5-10, 2017 | 63 | 2017 |
Randomized, controlled trial of prescribing training in a South African province JC Meyer, RS Summers, H Möller Medical education 35 (9), 833-840, 2001 | 62 | 2001 |
Knowledge and perceptions of antimicrobial stewardship concepts among final year pharmacy students in pharmacy schools across South Africa M Burger, J Fourie, D Loots, T Mnisi, N Schellack, S Bezuidenhout, ... Southern African Journal of Infectious Diseases 31 (3), 27-33, 2016 | 59 | 2016 |
Challenges and innovations brought about by the COVID-19 pandemic regarding medical and pharmacy education especially in Africa and implications for the future A Etando, AA Amu, M Haque, N Schellack, A Kurdi, AA Alrasheedy, ... Healthcare 9 (12), 1722, 2021 | 53 | 2021 |
Ongoing and planned activities to improve the management of patients with Type 1 diabetes across Africa; implications for the future B Godman, D Basu, Y Pillay, PHRF Almeida, JC Mwita, GM Rwegerera, ... Hospital practice 48 (2), 51-67, 2020 | 53 | 2020 |
Knowledge, attitudes and practices of health care professionals towards adverse drug reaction reporting in public sector primary health care facilities in a South African district HM Haines, JC Meyer, RS Summers, BB Godman European journal of clinical pharmacology 76 (7), 991-1001, 2020 | 52 | 2020 |
Compliance with the primary health care treatment guidelines and the essential medicines list in the management of sexually transmitted infections in correctional centres in … TB Matsitse, E Helberg, JC Meyer, B Godman, A Massele, N Schellack Expert review of anti-infective therapy 15 (10), 963-972, 2017 | 52 | 2017 |
Impact of a pharmacist-driven pharmacovigilance system in a secondary hospital in the Gauteng Province of South Africa A Terblanche, JC Meyer, B Godman, RS Summers Hospital practice 46 (4), 221-228, 2018 | 50 | 2018 |